On Apr. 29, 2010, Stanford University of researchers announced they had have used a healthy person’s complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications.

The risk analysis, from Stanford’s School of Medicine, also incorporated more-traditional information such as a patient’s age and gender and other clinical measurements. The resulting, easy-to-use, cumulative risk report brought the use of such data out of the lab and into the waiting room of average physicians within the next decade.